Author's Response to comments on: "Comparison of postoperative cyclosporine 2.0% versus betamethasone 0.1% eye drops following trabeculectomy: A randomized clinical trial". [PDF]
Indian J OphthalmolDaneshvar R.
europepmc +1 more source
Quadruple-drug induction therapy in highly sensitized patients [PDF]
, 1988 Abendroth, D. +3 more
core +1 more source
Adverse and Serious Adverse Events Associated With Tocilizumab in COVID-19 Pneumonia and With Cyclosporin, Pazopanib, and Insulin Glargine in Other Diseases: A Single-Center Cross-Sectional Study From a Tertiary Care Center in Bangladesh. [PDF]
CureusAhmed K +5 more
europepmc +1 more source
Comment on: Comparison of postoperative cyclosporine 2.0% versus betamethasone 0.1% eye drops following trabeculectomy: A randomized clinical trial. [PDF]
Indian J OphthalmolVaradhan N, Srikanth K.
europepmc +1 more source
Human papilloma virus (HPV) infection associated with cyclosporine-induced gingival overgrowth in renal transplant recipients. [PDF]
J Oral MicrobiolCossatis JJ +6 more
europepmc +1 more source
Effect of Cyclosporine Ophthalmic Solution 0.09% on Signs and Symptoms of Dry Dye Disease in Patients Inadequately Controlled on Cyclosporine Ophthalmic Emulsion 0.05%: Results from a Single-Arm, Open-Label, Phase 4 Study. [PDF]
Clin OphthalmolJohnston J +10 more
europepmc +1 more source
Kawasaki Disease in a Child With Trisomy 18 Treated With Initial Combination Therapy, Including Cyclosporine. [PDF]
Case Rep PediatrSahara Y +6 more
europepmc +1 more source
Cyclosporine related adverse events in aplastic anemia patients treated with immunosuppressive therapy. [PDF]
Ann HematolXing L +8 more
europepmc +1 more source
Recent improvement in clinical pancreas transplantation [PDF]
, 1987 Abendroth, D. +4 more
core +1 more source